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The uterus and heart share the important physiological feature whereby contractile
activation of the muscle tissue is regulated by the generation of periodic, spontaneous
electrical action potentials (APs). Preterm birth arising from premature uterine contractions
is a major complication of pregnancy and there remains a need to pursue avenues of
research that facilitate the use of drugs, tocolytics, to limit these inappropriate contractions
without deleterious actions on cardiac electrical excitation. A novel approach is to make
use of mathematical models of uterine and cardiac APs, which incorporate many ionic
currents contributing to the AP forms, and test the cell-specific responses to interventions.
We have used three such models—of uterine smooth muscle cells (USMC), cardiac
sinoatrial node cells (SAN), and ventricular cells—to investigate the relative effects of
reducing two important voltage-gated Ca currents—the L-type (ICaL) and T-type (ICaT) Ca
currents. Reduction of ICaL (10%) alone, or ICaT (40%) alone, blunted USMC APs with
little effect on ventricular APs and only mild effects on SAN activity. Larger reductions in
either current further attenuated the USMC APs but with also greater effects on SAN
APs. Encouragingly, a combination of ICaL and ICaT reduction did blunt USMC APs as
intended with little detriment to APs of either cardiac cell type. Subsequent overlapping
maps of ICaL and ICaT inhibition profiles from each model revealed a range of combined
reductions of ICaL and ICaT over which an appreciable diminution of USMC APs could be
achieved with no deleterious action on cardiac SAN or ventricular APs. This novel approach
illustrates the potential for computational biology to inform us of possible uterine and
cardiac cell-specific mechanisms. Incorporating such computational approaches in future
studies directed at designing new, or repurposing existing, tocolytics will be beneficial for
establishing a desired uterine specificity of action.
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INTRODUCTION
Computationalmodeling of an action potential (AP) of an electri-
cally excitable cell was first developed in 1952 with the landmark
study of neurons (Hodgkin and Huxley, 1952). Its success led to
the development of other models such as the tonic AP in car-
diac cells (Noble, 1960) and the bursting AP in β-pancreatic cells
(Chay and Keizer, 1983). In the intervening years there has been
an enormous advance in our understanding of the cardiac phys-
iome (Noble, 2007; Schmitz et al., 2011; Noble et al., 2012) and
computational analysis of electrical excitability now runs hand-
in-hand with physiological experimentation in heart research
(Crampin et al., 2004; Bassingthwaighte et al., 2009; Masumiya
et al., 2009; Nikolaidou et al., 2012; Zhang et al., 2012). Many
computational models exist to describe in considerable detail car-
diac cell-specific excitation-contraction properties, including the
biophysical details of the constituent ion currents and calcium
fluxes. These include multicellular tissue and organ maps of spa-
tiotemporal electrical and calciumwave propagation (Rudy, 2000;
Zhang et al., 2000; Kleber and Rudy, 2004; Severi et al., 2009;
Aslanidi et al., 2011b; Atkinson et al., 2011). Mathematical mod-
els are continuously being developed and applied to predicting
the risks of pathophysiological phenomena (e.g., the likelihood of
dyssynchronous activation and fibrillation) (Benson et al., 2008;
Bishop and Plank, 2012; Cherry et al., 2012; Kharche et al., 2012;
Behradfar et al., 2014) as well as the potential beneficial effects of
drugs and treatments (Levin et al., 2002; Muzikant and Penland,
2002; Davies et al., 2012; Mirams et al., 2012; di Veroli et al., 2013,
2014).
The uterus is also an electrically excitable tissue whose con-
tractile function is determined by episodic spontaneous APs
and calcium fluxes. Although our comprehension of the elec-
trophysiological basis of uterine AP formation lags behind that
of cardiac muscle, there is an increasing awareness that compu-
tational approaches, such as those which have been applied so
extensively to cardiac muscle, may foster advances in this matter
(Taggart et al., 2007; Aslanidi et al., 2011a; Tong et al., 2011; Sharp
et al., 2013). For example, we have developed a biophysically-
detailed uterine smooth muscle cell (USMC) model validated
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against experimental data and it can describe many different uter-
ine AP forms and the corresponding intracellular calcium changes
(Tong et al., 2011).
Utilizing computational models for the examination of uterine
APs offers the additional possibility of predicting the likely actions
of drugs that target ion channels or exchangers with the inten-
tion of attenuating premature uterine contractions. Hitherto,
such tocolytics have been used clinically without prior extensive
in silico assessment of effectiveness. Uterine APs, and the resul-
tant contraction of smooth muscle cells, are markedly dependent
upon the activation of a prominent voltage-gated inward (depo-
larizing) current, the long-lasting L-type calcium current (ICaL).
Nifedipine, an L-type voltage-gated calcium channel blocker,
is currently used as a tocolytic treatment (RCOG, 2011). This
treatment is useful for delaying labor in the short term (Conde-
Agudelo et al., 2011). However, it is not without adverse side
effects, in particular on maternal cardiovascular performance
(van Veen et al., 2005; Guclu et al., 2006; Gaspar and Hajagos-
Toth, 2013), and it is not presently recommended for longer-term
use, nor for women with cardiac disease (RCOG, 2011). This
alerts one to another necessary consideration of tocolytic drugs
intended to limit uterine APs namely, what possible actions may
there be on cardiac electrical excitability?
Another voltage-gated Ca current, in addition to ICaL, that,
theoretically, may be a suitable target for developing tocolytic
drugs is the short-lasting, transient T-type Ca channel current
(ICaT). T-type calcium currents are believed to play a role in pace-
making in many cell types (Mangoni et al., 2006; Perez-Reyes
et al., 2009). ICaT has been observed in uterine tissues (Inoue et al.,
1990; Young et al., 1991, 1993; Blanks et al., 2007) and putative
blockers of ICaT reduce in vitro uterine contractions (Lee et al.,
2009). ICaT has a different current-voltage (I-V) profile from ICaL
and, unlike the latter, there is considered to be little ICaT present
in ventricular cardiomyocytes although it has been suggested to
contribute to sinoatrial (SA) node APs (Ono and Iijima, 2010;
Mesirca et al., 2014).
Our over-arching objective was to utilize computational mod-
els of uterine and cardiac cells to theoretically test the possible
cell-specific effects of inhibiting voltage-gated Ca entry (ICaL and
ICaT) in a manner that may be anticipated to occur with drugs
targeting these pathways. Using publicly-available computational
models of uterine and cardiac APs we have performed a series of
simulation experiments to investigate the following questions:
(i) Are there comparable effects on uterine and cardiac APs of
reducing ICaL?
(ii) Are there similar effects on uterine and cardiac APs of
reducing ICaT?
(iii) Does combined reduction of ICaL and ICaT have differential
actions on uterine and cardiac APs?
METHODS
UTERINE SMOOTH MUSCLE CELL MODEL
For these simulation studies we used our previously published
USMC model (Tong et al., 2011). A schematic of the ionic cur-
rents contributing to themodel is shown in Figure 1A. Themodel
FIGURE 1 | Schematic diagrams of the ionic currents in each of the
three cell models. (A) Uterine smooth muscle cell model (USMC) (Tong
et al., 2011), (B) rabbit sinoatrial nodal cell model (SAN) (Garny et al., 2003),
(C) modified guinea pig ventricular cell model (LRd00) (Faber and Rudy,
2000). The lollipop sign indicates channels that are voltage-gated. The
L-type Ca channel and T-type Ca channel, carrying ICaL and ICaT, respectively,
are indicated in red.
source code, parameter values and the full description are pro-
vided in Tong et al. (2011). All the USMC AP simulations were
started at the same resting state. The numerical values of all
the dynamical variables at this state—the initial conditions—are
provided in the Supplementary Materials.
CARDIAC CELL MODELS
There are numerous computational models of cardiac cells and
many are listed in the CellML model repository (http://models.
cellml.org/). They represent different parts of the heart from the
central and peripheral sinoatrial nodal cells (Zhang et al., 2000;
Garny et al., 2003), the atrial cardiomyocytes (Aslanidi et al.,
2009), the atrial-ventricular node and His-bundle (Inada et al.,
2009), Purkinje fiber cells (Stewart et al., 2009; Li and Rudy, 2011)
and ventricular cardiomyocytes (Faber and Rudy, 2000). These
cell types can be grouped, rather roughly, into those of a contrac-
tile or conducting function. In our preliminary simulations using
these cardiac models, we selected the ventricular and sinoatrial
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nodal cell models that showed the greatest propensity to alter AP
form following a reduction of Ca current thus forming the most
sensitive situation for comparing the same maneuvre to that on
the USMC model.
For the sinoatrial nodal cell, we used the Garny et al. (2003)
rabbit sinoatrial nodal cell model (SAN) and its 0D-capable ver-
sion configurations for the SAN central cell. A schematic of the
ionic currents contributing to the model is shown in Figure 1B.
The model equations and parameter values and are listed in the
CellML model repository. The initial conditions for the SAN
model are provided in the Supplementary Materials.
For the ventricular cardiomyocyte cell, we used as a plat-
form the Faber and Rudy (2000) guinea pig cell model (LRd00)
and its M cell configurations. A schematic of the ionic current
components of the model is shown in Figure 1C. The model
equations, parameter values and initial conditions are listed in the
CellML model repository. A copy of the model source code can
also be downloaded from http://rudylab.wustl.edu/research/cell/
methodology/cellmodels/LRd/code.htm. However, as detailed
below in the Results, we had to modify this model in order to
incorporate a more robust description of ICaT. The LRd00 mod-
ified model was paced for 20min at 2Hz to allow it to reach a
stable state with its M cell configurations. Then, the values of all
the dynamical variables in this stable state were saved: these stable
state conditions of the modified LRd00 model are provided in the
Supplementary Materials.
SIMULATIONS OF UTERINE AND CARDIAC APs WITH REDUCED ICaL
AND ICaT
The effects of reduced ICaL and ICaT on the uterine and cardiac
APs were assessed and quantified. The ICaL and ICaT were reduced
by multiplying their maximal conductances with a scaling factor
between 0 and 1 and we assumed the same proportional reduc-
tion would occur in all three cell types. As the APs between the
three unique cell types have different forms and characteristics, it
is difficult to use a common measure to assess their AP behaviors.
Therefore, we chose to assess a characteristic that best reflects the
main function of each of the cell types: the bursting activities in
the uterine cell, the pacemaking ability of the SAN cell and the
action potential duration (APD) of the ventricular cell. For the
USMC model, after adjusting the levels of ICaL and ICaT, an AP
was induced by a 5 s current clamp at−0.5 pA pF−1 and the max-
imal peak membrane voltage (Vpeak) reached after the first initial
spike was measured. This assessment gives an indication of the
presence or absence of bursting spikes in a USMCAP. For the SAN
model, after adjusting the levels of ICaL and ICaT, the model was
simulated for 10 s and the pacemaking frequency was measured
from the APs in the last 2 s of simulations. For the LRd00 model,
an AP was induced by a 0.5ms current pulse at −90 pA pF−1 and
the APD at 90% repolarization level (APD90) was assessed.
All simulations were computed using XPPAUT Version 6
(Ermentrout, 2002) in a Dell Optiplex PC with an Intel(R)
Core(TM) i7-3770 CPU @ 3.40GHz. For the USMC model, all
simulations were computed with a fixed time step of 0.02ms
and the Euler method. For the SAN model, all simulations were
computed with a fixed time step of 0.1ms and the fourth-order
Runge–Kutta method. For the LRd00 model, all simulations were
computed with a fixed time step of 0.002ms and the fourth-order
Runge–Kutta method.
RESULTS
VALIDATION OF THE CELL MODELS
We first verified each source code of the three individual cell mod-
els with their respective published results. Both the USMC and the
SAN models were validated in this regard. Surprisingly, we found
that the LRd00 model could not be validated so in respect of ICaT:
the simulated current tracings (Figure 2A), and the correspond-
ing current-voltage (I-V) relationship (Figure 2B), of the LRd00
model did not match the experimental results that they were rated
against (Balke et al., 1992). The simulations produced current
responses at membrane voltages that were much farther to the
right (positive) than observed in the experimental data or, indeed,
to that anticipated from other ICaT models. When we traced back
the original formulation of this ICaT to Zeng et al. (1995), and the
experimental values from which its kinetics details were based to
Droogmans and Nilius (1989), we did not find any typographi-
cal errors in the model equations or the experimental values to
explain the discrepancy. As an aim of our study was to investi-
gate the effects of altering ICaT, it was essential that the models
incorporated the correct formulations. We were left, therefore,
with no option but to attempt to modify the ICaT in the LRd00
model such that it did reflect more closely the experimental data.
For those interested in the details of this process, our attempts to
modify the model were undertaken as follows: we had first tried,
but failed, to produce a reasonable ICaT model by either adjust-
ing the LRd00 ICaT equations or reformulating new equations
using data from Droogmans and Nilius (1989). We next tried
substituting the LRd00 ICaT with a validated ICaT model from
Li and Rudy (2011), which was developed for canine Purkinje
fiber cells. The simulated current tracings with this canine ICaT
resemble the ICaT current tracings in Balke et al. (1992) but the
kinetics were too fast and the peak of the I-V relationship was
still too positive compared to the experimental data from Balke
et al. (1992). Using the ICaT from Li and Rudy (2011) as our
template, we corrected the differences between the simulations
and the experimental data with the modifications that resulted
in Equations (1–8) for the new ventricular ICaT that are listed in
the Supplementary Materials. As discussed by Droogmans and
Nilius (1989), we also found that the kinetics of the ventric-
ular ICaT currents were best described by a gating product of
b2g where b and g are gating variables for activation and inac-
tivation (Equation 1 in the Supplementary Materials). The I-V
data in Balke et al. (1992) was matched with a half-activation
at −50mV in the activation steady-state function (Equation 3 in
the SupplementaryMaterials). Although this half-activation value
deviated from the reported value for ICaT (Droogmans andNilius,
1989), it is similar to those reported values from clonal Cav3.1
expression data (Serrano et al., 1999; Hering et al., 2003). As the
kinetics of the canine ICaT model were too fast compared to the
ventricular cell experimental data within the LRd00 model (i.e.,
the data from Balke et al., 1992), we slowed down the activation
and inactivation by scaling the time constants (Equations 5, 6 in
the Supplementary Materials). The resultant new ICaT model sat-
isfactorily described the ventricular ICaT data (Balke et al., 1992)
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FIGURE 2 | Incorporation of a modified T-type calcium current model for
LRd00. The original ICaT contained in the LRd00 cardiac ventricular cell model
did not behave like a T-type calcium current. The simulated raw current
tracings (A) and the I-V current plots (B) appeared at holding membrane
potentials farther to the right than of the experimental data of Balke et al.
(1992) that was used as a source experimental dataset. Simulated current
tracings at five different voltage steps from a holding potential of −90mV (A)
and simulated peak current-voltage (I-V) relationships (B) of the original and
modified ICaT currents are shown in comparison to the experimental data
from Balke et al. (1992). All current tracings were normalized to their maximal
peak current from their I-V relationships. The modified ICaT now closely
resembled the experimental data. (Experimental tracings and data, adapted
with permission from Figure 4 from Balke et al. (1992); copyright 1992 The
Physiological Society.)
and we replaced the original LRd00 ICaT with this new ICaT model.
The ratio between peak ICaT and ICaL in guinea pig ventricular
cells are reported to be between 0.13 and 0.19 (Balke et al., 1992;
Masumiya et al., 1998; Zorn-Pauly et al., 2004). Therefore, we
chose a value for themaximal conductance of our new ICaT model
(g¯CaT) so that the ratio of the maximum ICaT: ICaL in the modified
LRd00 cell model was 0.15.
NORMAL USMC, SAN, AND VENTRICULAR APs
USMC APs can take a variety of forms of variable durations.
Bursting type USMC AP, wherein an initial spike of an AP fol-
lowed by rapid and repetitive fluctuations in membrane potential
that persist for the whole AP duration, are often observed. These
may assist in the maintenance of long-duration contractions of
many tens of seconds that are a feature of the uterus during labor.
Therefore, a promising feature of a tocolytic would be one that
could dampen, or delay, the bursting in the USMC APs with min-
imum effects on the APs of the cardiac SAN and the ventricular
cells.
Figure 3A shows the simulated APs from the three cell mod-
els under control conditions before any maneuvre. The USMC
model showed a resting membrane potential (RMP) of−55.5mV
before stimulation. During the evoked USMC AP, burstings
occurred throughout the AP with a frequency between 2 and
2.54Hz and the amplitudes of the repetitive spikes were around
40mV. The Vpeak after the initial spike was −7mV. The SAN
cell is autorhythmic where periodic APs occur without external
stimulation. The frequency and amplitude of the pacemaking
activities were 3.15Hz and 75mV (between −56 and 19mV),
respectively. These values were the same throughout the whole
10 s simulation. The LRd00 ventricular cell showed a compara-
tively hyperpolarized (negative) RMP at−87mV. A single AP was
evoked in respond to a stimulus and the ventricular APD90 was
165ms. These quantified characteristics are the reference values
before any maneuvre.
EFFECTS OF REDUCING ICaL IN UTERINE AND CARDIAC CELLS
ICaL is a major depolarization current in USMCs and thus a
logical target for tocolytics. We examined the effect of reduc-
ing ICaL by 10% (Figure 3B). In the USMC model, this change
dampened the initial repetitive spikes of the USMC AP and
reduced the duration of the burstings by around 60%. The
amplitudes of the remaining, late-onset, bursting spikes were
reduced by 30% to about 28mV and the Vpeak of the USMC
AP was lowered to −14.8mV. A less severe effect of 10% less
ICaL was evident in the APs from the SAN and the LRd00
models. The amplitude of the SAN pacemaking APs was mod-
estly reduced by 12% and the frequency remained unchanged.
The LRd00 APD90 was slightly reduced by 5%. When ICaL
was reduced by 20% (Figure 3C), the burstings of the USMC
AP were suppressed completely. However, the SAN cell also
stopped pacemaking. The LRd00 APD90 was slightly reduced
by ∼10% at 150ms. These data indicated that although reduc-
ing some ICaL suppressed uterine bursting APs, this maneu-
vre also affected both the cardiac pacemaker APs and the
ventricular AP.
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FIGURE 3 | Effects of reducing ICaL in uterine and cardiac cells. Effects on
the action potential forms and characteristics with reduced ICaL in different
cell types: the USMC cell model (left), the SAN cell model (center), and the
LRd00 ventricular cell model (right). (A) Control configuration at full ICaL and
the effects of reducing ICaL by (B) 10% and (C) 20%. The negative sign
indicated reduction.
EFFECTS OF REDUCING ICAT IN UTERINE AND CARDIAC CELLS
ICaT may be one of the SAN pacemaking currents in the heart
and may also be involved in the generation of APs in USMCs. The
effects of our maneuvres to reduce ICaT in each of the three cell
types are shown in Figure 4. The control cases of the three models
are displayed in Figure 4A. Reduction of ICaT by 40% (Figure 4B)
delayed the onset of the burstings in the USMCAP. However, both
the Vpeak and the amplitude of the later-onset burstings remained
the same as the control. With 40% less ICaT, the pacemaking by
the SAN cell slowed down to about 2.94Hz with the peak poten-
tial at a slightly lower level of 15mV. Reduction of ICaT by 40%
did not affect the LRd00 APD90. When more ICaT was reduced,
by 80% (Figure 4C), the onset of the USMC burstings was fur-
ther delayed with only one spike appearing at the end of the AP.
However, the amplitude of this spike was similar in size to those
of the control. Also, the RMP level became more hyperpolarized
at∼ −57mV.With this large reduction of ICaT (by 80%), the SAN
pacemaking APs slowed down to 2.63–2.7Hz. The pacemaking
potential in the SANmodel remained at the same level at−56mV
but the peak potential was lowered to 12mV. At this level, the SAN
model also showed a longer (∼0.5 s) transient during simula-
tion. With 80% less ICaT, the LRd00 APD90 remained unchanged.
Without ICaT (Figure 4D), the RMP level of the USMC became
more hyperpolarized at∼ −58mV and the bursting of the USMC
AP stopped. The SAN pacemaking also ceased without ICaT but
the LRd00 AP was unaffected. These data indicated that reduction
of ICaT suppressed the uterine bursting AP with no impact on
the ventricular AP. However, depending on the magnitude of ICaT
reduction, there was also an effect on the SAN APs.
EFFECTS OF REDUCING ICaL AND ICaT IN UTERINE AND CARDIAC
CELLS
The above data suggested that there was some promise in reduc-
ing either ICaL or ICaT and effecting an inhibition of USMC APs
with little deleterious action on ventricular APs. The manouevres
that reduced ICaL or ICaT and had mild effects on SAN AP may
be tolerable. However, reductions in either current that effected
a larger inhibition of uterine APs, as one may desire the action
of a tocolytic in our experimental setting to be, also had dra-
matic actions on SAN AP form. The outcomes of reducing ICaL
or ICaT in the USMCmodels were slightly different: reducing ICaT
altered the RMP and the onset of spike bursting whereas changes
in ICaL had a predominant action on spike amplitude. This begat
the question, could a combined reduction of ICaL and ICaT exert
the desired action on USMC APs with little impact on cardiac
cell APs? An example is illustrated in Figure 5. The control cases
of the three models are shown in Figure 5A and the effects of
reducing only ICaL by 10%, or only ICaT by 40%, are illustrated
again in Figures 5B,C, respectively. This enables comparison to
the effect arising when both ICaL and ICaT were reduced, by
10 and 40%, respectively, (Figure 5D). In this case, the burst-
ings of the USMC AP were completely suppressed (Figure 5D).
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FIGURE 4 | Effects of reducing ICaT in uterine and cardiac cells. Effects on
the action potential forms and characteristics with reduced ICaT in different
cell types: the USMC cell model (left), the SAN cell model (center), and the
LRd00 ventricular cell model (right). (A) Control configuration at full ICaT and
the effects of reducing ICaT by: (B) 40%, (C) 80%, and (D) 100%. The
negative sign indicated reduction.
With this combination, the pacemaking frequency of the SANAPs
remained the same at 3.125Hz and the amplitude was reduced
by 20% (from −52 to 7.7mV). The LRd00 APD90 was slightly
reduced by ∼4% to 158ms. Compared to the cases when only
either ICaL or ICaT were reduced alone to completely suppress
the burstings of the USMC AP (Figures 3C, 4D), this combined
approach clearly performed better while preserving many of the
properties of the cardiac APs.
We plotted two-parameter maps of percentage current
inhibitions—of ICaL vs. ICaT—in each cell model to exam-
ine the effective ranges of different combinations of ICaL and
ICaT reductions on the properties of uterine and cardiac APs
(Figure 6). After the initial spike of a USMC AP, the peak of
the bursting spikes typically reach values between −20 and 0mV
whereas without bursting, the plateau AP voltage usually stayed
below −30mV. Therefore, we assessed the presence or absence
of burstings in a USMC AP from the level of Vpeak when the
proportions of ICaL and ICaT were changed and the results of
the parameter plots are color-coded in Figure 6. In Figure 6A,
the white region indicated the combinations of ICaL and ICaT
that would produce a USMC AP with some burstings and the
shaded region indicated the combinations of currents with which
the USMC cell would not produce such activity. The USMC AP
example shown previously in Figure 5D, with 10% reduction of
ICaL and 40% reduction of ICaT, lay just within the non-bursting
domain (as indicated by the green star). For the SAN cell, the
pacemaker frequency was monitored as one changed the propor-
tions of ICaL and ICaT and the results are shown in Figure 6B. The
colored domain indicated pacemaking occurrence and the white
region suggested the parameter combinations would result in no
pacemaking. The frequencies of the pacemaking APs were simi-
lar throughout the pacemaking zone and the transition between
the two regions was steep (not shown). The SAN example shown
in Figure 5D with 10% reduction of ICaL and 40% reduction of
ICaT was within the pacemaking region. For the LRd00 ventric-
ular cell, the APD90 was monitored as the proportions of ICaL
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FIGURE 5 | Effects of reducing ICaL and ICaT in uterine and cardiac
cells. Effects on the action potential forms and characteristics when both
ICaL and ICaT were proportionally reduced in different cell types: the USMC
cell model (left), the SAN cell model (center), and the LRd00 ventricular
cell model (right). (A) Control configuration before reducing either of the
currents. (B) Reducing ICaL by 10% only. (C) Reducing ICaT by 40% only.
(D) Reducing ICaL by 10% and ICaT by 40%. The negative sign indicated
reduction.
and ICaT were changed and the results are shown in Figure 6C.
Changes in the APD90 occurred only with changes in ICaL, indi-
cating that ICaT did not influence the APD of the ventricular cell
model. From overlapping these parameter maps, we derived the
boundaries of combinations of ICaL and ICaT for attaining spe-
cific sets of AP forms in the uterine and cardiac cells as shown
in Figure 6D. The colored lines separate different properties of
the uterine and cardiac cells obtained from the simulations in
Figures 6A–C. The blue line traces the level of Vpeak at −30mV
in the parameter space of ICaL and ICaT of the USMC cell model
and it separates the bursting and quiescent conditions. The red
line separates the pacemaking conditions with ICaL and ICaT in
the SAN cell model from the non-pacemaking. We allowed for
10% variations in the APD90 of the LRd00 ventricular cells and
this threshold at 150ms was indicated by the gray line. These
three criteria were superimposed on the same parameter map of
ICaL and ICaT and revealed an overlapping area that satisfied all
three conditions. In other words, any combination of reduced ICaL
and ICaT within this area can produce our desired outcome for
tocolytic treatment, namely, effective suppression of USMC APs
with minimal effects on cardiac APs.
The above experiments have considered the outcomes on AP
formwhen imposing the same proportional reduction of ICaL and
ICaT in all three cell types. However, another interesting possibility
would be the same absolute quantities of currents being reduced
in all three cell types. This consideration arises from examining
the range of current densities of ICaL and ICaT reported from the
different cell types as noted in Table 1. Cells of the cardiac con-
duction system tend to have much more ICaT than contractile
cardiomyocytes and, when comparing between uterine and car-
diac cell types, the total ICaT found in USMCs amounts to around
42% of that reported from guinea pig SAN. We re-performed our
simulations to test the effects of reducing the same quantities of
currents in each of the three cell type models. This resulted in a
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FIGURE 6 | Summarized effects of different combinations of reduced ICaL
and ICaT on the APs of the three different cell types. The shaded areas in
the 2-parameter maps indicate the type of AP that would be produced with
the different combinations of proportionally reduced ICaL and ICaT: (A)
suppressed bursting in the USMC cell model, (B) pacemaking activities in the
SAN cell model, and (C) less than 10% change in the action potential duration
at 90% repolarization level (APD90) in the LRd00 ventricular cell model. The
green star illustrates the corresponding position on each 2-parameter map of
the example shown in Figure 5D, i.e., with reductions of 10% ICaL and 40%
ICaT. (D) Combinations of ICaL and ICaT (green area) that would suppress
bursting in the USMC without affecting the pacemaking in the SAN cell or the
APD90 in the LRd00 ventricular cell.
transformation of the XY axes of the parameter maps in Figure 6
to current densities and the result is shown in Figure 7. Now, the
simulations reveal a larger domain within which one may reduce
ICaL and ICaT to produce effective inhibition of USMC model
APs with little detriment to cardiac cell model APs. In particu-
lar, it is possible to completely block the USMC bursting by large
reduction of the USMC ICaT without affecting the SAN pacemak-
ing. Therefore, our first experimental protocol of examining the
effects of proportional current reductions likely represents the
most stringent case.
DISCUSSION
Muscle contractions are determined by the form and duration
of the preceding APs and the corresponding calcium fluxes. ICaL
is involved in the depolarization of APs and is a major source
of calcium influx in many excitable cell types including uterine
smooth muscle and cardiac muscle cells. As it has been shown
in experimental studies (Kodama et al., 1997; Terrar et al., 2007;
Lee et al., 2009; Young and Bemis, 2009) and in this study, reduc-
ing ICaL affects the amplitude and the duration of the AP and/or
contractile force in these cell types. These properties made ICaL
an obvious choice as a target for tocolytic treatment. Indeed,
nifedipine is used clinically as a second line tocolytic for short
periods and within tight dosage recommendations; caution in its
use is warranted because of the possibility of side effects including
palpitations and hypotension (van Geijn et al., 2005; RCOG,
2011). This alerts one to a necessary consideration of the pos-
sible actions on cardiac electrical excitability by tocolytic drugs
intended to limit uterine APs.
From our simulations, the USMC model seems to be more
susceptible to reduced ICaL than the two cardiac (SAN and ven-
tricular) cell models. However, the influence on the cardiac SAN
model of reducing ICaL appears rather steep and so, as one
attempts to increase the USMC effects by greater ICaL reductions,
there too is a potentially damaging influence on SAN activity and,
by extension, heart pacing. This may relate to the side effects on
cardiac functions and the tight dosage guidelines recommended
for nifedipine use as a tocolytic (RCOG, 2011).
With its potential role in facilitating the onset of USMC APs,
ICaT is an alternative tocolytic target. The RMP of USMCs of
around −55mV is close to the voltage level for the window
current from ICaT (Blanks et al., 2007). However, experimental
studies in cardiac SAN cells illustrate that maneuvres designed
to reduce ICaT result in alterations of SAN APs (Hagiwara et al.,
1988; Masumiya et al., 1998; Tanaka et al., 2008). In our study,
modest reduction of ICaT hyperpolarizes the USMC model RMP
and diminishes the bursting spikes with a mild effect on the SAN
model cell AP. However, as above for ICaL, further reductions in
ICaT with the purpose of abrogating USMCmodel APs resulted in
deleterious actions on the SAN cell model APs.
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Table 1 | Summary of ICaL and ICaT current density ranges reported in
uterine and cardiac cells.
Tissue type Species ICaL (pA pF-1) ICaT (pA pF-1) References
Uterus Rat 1.49–7.17 1–8
Human 0.65–4.5* 0.89–2.32* 9–13
SA node Guinea pig 2.8–4.6 3.0–5.4 14–16
Mice 4.4–7.6 5.2–8.4 17
Rabbit 22 2–6 18, 19
Pig 3.1 n.d. 16
AV node Mice 3.6–4.6 5 17
Purkinje cells Canine 2.28–6.1 0.99–4.6 22–24
Atrial cells Guinea pig 4.66–6.36* 2.21–2.55* 20, 21
Mice 6.0–8.0 n.d. 17
Ventricular cells Guinea pig 4.33–12.5* n.d.–1.97 21, 25–28
n.d., Not detected.
*Some experimental values were reported in pA and they were converted
to pA pF−1 with published capacitances: late pregnant human myometrium
(Cm = 140 pF, Blanks et al., 2007); guinea pig atrial cells (Cm = 44 pF); and ven-
tricular cells (Cm = 115 pF, James et al., 1996).
References: 1, Ohya and Sperelakis, 1989; 2, Inoue and Sperelakis, 1991; 3,
Miyoshi et al., 1991; 4, Kusaka and Sperelakis, 1995; 5, Yoshino et al., 1997; 6,
Shmigol et al., 1998; 7, Okabe et al., 1999; 8, Jones et al., 2004; 9, Inoue et al.,
1990; 10, Young et al., 1991; 11, Young et al., 1993; 12, Knock and Aaronson,
1999; 13, Blanks et al., 2007; 14, Kojima et al., 2012; 15, Kojima et al., 2014; 16,
Ono and Iijima, 2005; 17, Mangoni et al., 2006; 18, Hagiwara et al., 1988; 19,
Ono and Iijima, 2010; 20, Xu and Lee, 1994; 21, Camara et al., 2001; 22, Hirano
et al., 1989; 23, Han et al., 2001; 24, Rosati et al., 2007; 25, Balke et al., 1992;
26, Masumiya et al., 1998; 27, Takeda et al., 2004; 28, Zorn-Pauly et al., 2004.
In contrast, our data suggests that reducing both ICaL and ICaT
can confer advantages for achieving our objective. This strategy
may facilitate delaying/slowing the onset of the USMCAPs. In our
simulations, this combined approach clearly works more effec-
tively than reducing either of the currents alone. Furthermore,
we have identified a range of desirable combinations of ICaL and
ICaT inhibition for maximizing the desirable action on USMC
model APs without attracting an adverse effect on cardiac SAN
or ventricular cell model APs.
If this approach is to work, then there will have to be an agent
that blocks ICaT with at least as good selectivity as nifedipine for
ICaL. Mibefradil has been suggested to be a selective T-type Ca
channel blocker but there are several studies indicating that it can
affect both L-type and T-type calcium channels (Masumiya et al.,
1999; Protas and Robinson, 2000; de Paoli et al., 2002). From such
a seeming disadvantage, could one utilize the cross-channel inhi-
bition of a particular drug for the purposes described above? i.e.,
might the use of one drug eventuate the situation of beneficially
inhibiting both ICaL and ICaT? Mibefradil, at 1μM, was shown
to block 55% of ICaT in rabbit sinonatrial nodal cells (Protas and
Robinson, 2000) but also and 64% of ICaL; at 3μM, it blocked
28% of ICaT and 15% of ICaL in guinea pig ventricular cells (de
Paoli et al., 2002); at 10μM, it inhibited 90% ICaT in guinea pig
ventricular cells (Masumiya et al., 1999) and also 40% ICaL. If we
compare these combinations of proportional inhibitions of ICaL
FIGURE 7 | Effects of the same absolute amounts of ICaL and ICaT
reductions on the APs of the three different cell types. A transformation
of the simulation results in Figure 6D using the maximum values from
published experimental current densities of ICaL and ICaT (Table 1) in human
uterine smooth muscle cells (ICaL = 4.5pA pF−1 and ICaT = 2.32pA pF−1),
guinea pig SAN cells (ICaL = 4.6pA pF−1 and ICaT = 5.4pA pF−1), and
guinea pig ventricular cells (ICaL = 12.5 pA pF−1 and ICaT = 1.97 pA pF−1).
The dashed lines are the experimental limits of ICaL and ICaT that can be
reduced in the different cell types. The solid color lines and the green area
represented the same conditions as in Figure 6.
and ICaT against our results in Figure 6, all of these combinations
fall outside our desired proportional mix of these two currents
for a useful tocolytic treatment. Instead, based on our simu-
lation results, if mibefradil was used as tocolytic treatments at
these concentrations, it might reduce uterine bursting APs but it
would likely affect cardiac pacemaking functions as well. Indeed,
mibefradil, at 1μM, was shown to attenuate the contractile forces
of uterine muscle strips from late pregnant rats (IC50 ∼1μM,
Lee et al., 2009). However, at the same concentration, mibefradil
also reversibly stopped the pacemaking activities from sinoatrial
nodal cells (Protas and Robinson, 2000). Thus, it would seem
that the dual actions, and limited channel-specific discretion, of
mibefradil on ICaL and ICaT would not be advantageous to our
purpose in both in silico and in vitro experimental settings. In
addition, it has been reported to have inhibitory actions on a
number of non-Ca channels including INa(1.5), a major Na current
in cardiomyocytes (McNulty and Hanck, 2004). This highlights
another issue, therefore, in the prosecution of these studies in the
longer-term, i.e., that the development of inhibitors with greater
selectivity for T-type Ca channels would be a major advance.
In this in silico assessment of potential tocolycis, not only did
we consider the effectiveness of action on the uterus, but we also
assessed the possible side effects to different cells of the heart. This
approach is only possible as the computational models of both
organs are developed with sufficient biophysical details. The most
obvious limitation for this kind of assessment is that it depends
on the depth and accuracy of biophysical details in the compu-
tational models. We can only include quantitative details from
www.frontiersin.org October 2014 | Volume 5 | Article 399 | 9
Tong et al. Uterine and cardiac action potentials
experimental data but often we are forced to make assumptions
and educated guesses for the unknowns. Indeed, we have seen
in our study that close scrutiny of existing models, however well
established, can reveal anomalies that need addressing—in our
case the ICaT characteristics in the ventricular cell model—before
experimental simulations with particular purposes can be tested.
This is the benefit of the iterative process. As computational
models continue to be tested, and evolved to incorporate new
and relevant biophysical details, the accuracy of the quantitative
predictions will improve.
FUTURE DIRECTIONS
Our work brings to the fore the notion that, instead of searching
for a single tocolytic compound with high specificity, there may
be merit in considering a cocktail of more than one compound.
The present recommendations in the UK are to avoid combina-
tions of tocolytic drugs for fear of increasing the risk of side effects
(RCOG, 2011). However, this caution arises from a lack of depth
to the background research data and the paucity of currently
available tocolytic options. The progression to labor has been
described as a modular accumulation of (patho)physiological
systems—or MAPS—and it is such modularity that is a major
challenge to overcome in seeking to prevent or inhibit labor
(Mitchell and Taggart, 2009). The suspicion is that once module
A of the labor process is inhibited, there is module B, or module C
or more that eventually facilitates a similar function and outcome
of labor and delivery. If this is so, then the possibilities offered by
combination drug strategies must continue to be explored.
Our assessment only considered effects at the cell level.
However, to fully evaluate the actions of any tocolytic com-
pounds, we need to also consider their effects at the tissue
and organ levels. Currently there is no validated computational
organ model for the uterus that would serve well this purpose
although it is recognized by many that efforts toward this are
required (Aslanidi et al., 2011a; Sharp et al., 2013). We are
under no illusion that there is a need for much more “wet”
experimentation—particularly in USMCs—to furnish computa-
tional model improvement, and to test with increasing rigor and
clarity, important hypotheses of relevance to tocolysis.
CONCLUSION
Our approach herein can be regarded as a useful platform to
be built upon for assessing the potential of tocolytics that act
upon ion channels or electrogenic ion exchangers. Using the in
silico approach described above enables future research to assess
in parallel the potential benefits of attenuating premature uter-
ine contractions vs. the risks of deleterious actions on cardiac
electrical excitation.
Encouraging such in silico assessments at the early stages of
laboratory or clinical studies will foster an integrated and iterative
process between mathematical modeling and experimentation
such that each informs the other. Related to this, it can alert one
to the possibility of otherwise unforeseen actions of drugs and
inform the subsequent protocol development for experimenta-
tion. Not only will this be beneficial in the examination of new
physiological mechanisms and the actions of novel drugs but it
will be useful, as indicated in this study, for the investigation of
repurposing the application of existing drugs. It is to be hoped
that similar approaches may form part of forthcoming scientific
and clinical scientific strategies.
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